Biofourmis Funding & Investors
Boston, MA
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. The company discovers, develops, and delivers clinically validated software-based therapeutics to enable better outcomes for patients. These solutions include advanced tools for clinicians to deliver personalized care and cost-effective solutions for payers. Biofourmis was founded in 2015 and headquartered in Boston, Massachusetts.
https://biofourmis.com/Total Amount Raised:
Biofourmis Funding Rounds
Series D
$20,000,000
Series D Investors
Intel CapitalSeries D
$300,000,000
Series D Investors
General AtlanticCVS HealthOpenspace VenturesEDBISeries C
$100,000,000
Series C Investors
SoftBank Vision FundMMV Europe & Asia-PacificEDBISequoia CapitalOpenspace VenturesCapikris FoundationSeries B
$35,000,000
Series B Investors
MMV Europe & Asia-PacificPeak XV PartnersEDBISGInnovateAviva VenturesOpenspace VenturesJiankeSeries A
$2,000,000
Series A Investors
SGInnovateAviva VenturesSeries A
$5,000,000
Series A Investors
Aviva VenturesOpenspace VenturesSeed
$500,000
Seed Investors
SpesNetAngel
$1,000,000
Angel Investors
Eden Strategy InstituteSpesNetAngel
71,051 SGD
Angel Investors
Eden Strategy Institute
Funding info provided by Diffbot.